Senthil, Maheswari http://orcid.org/0000-0002-0339-8558
Dayyani, Farshid
Article History
Received: 22 August 2023
Accepted: 23 August 2023
First Online: 8 September 2023
Disclosure
: Farshid Dayyani receives institutional research support from Astrazeneca, BMS, Merck, Exelixis, Taiho, Trishula, Natera, Amgen, Genentech/Roche, and Ipsen; honoraria from Exelixis, Sirtex Medical, Eisai, Astellas, and Servier; and consulting fees from Exelixis, Eisai, and Astrazeneca. Maheswari Senthil has no conflicts of interest.
Free to read: This content has been made available to all.